Author:
Sigle August,Michaelis Jakob,Schöb Dominik,Benndorf Matthias,Schimmöller Lars,Becker Benedikt,Pallauf Maximilian,Gross Andreas J.,Herrmann Thomas R. W.,Klein Jan-Thorsten,Lusuardi Lukas,Netsch Christopher,Häcker Axel,Westphal Jens,Jilg Cordula,Gratzke Christian,Miernik Arkadiusz
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142(1):71–74 (discussion 4–5)
2. Schoots IG, Padhani AR (2020) Delivering Clinical impacts of the MRI diagnostic pathway in prostate cancer diagnosis. Abdom Radiol 45(12):4012–4022
3. van der Leest M, Cornel E, Israel B, Hendriks R, Padhani AR, Hoogenboom M et al (2019) Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naive men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol 75(4):570–578
4. Halpern EJ, Strup SE (2000) Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 174(3):623–627
5. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Langversion 5.1, 2019. AWMF Registernummer: 043/022OL, http://www.leitlinienprogramm-onkolo-gie.de/leitlinien/prostatakarzinom/.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献